Public health has its own bracket of champions: breakthroughs that eliminated deadly diseases, revolutionized surgery, and opened entirely new doors in medicine. From vaccines to mRNA technology, ...

Tomorrow BioTech and The Super Crowd join forces to give biotech startups labs, crowdfunding, and capital to turn ...

CNS Pharmaceuticals (CNSP) announced John Climaco has stepped down as CEO of CNS Pharmaceuticals and Rami Levin, MBA, has been appointed as President & CEO. Levin will join CNS effective January 1, ...

MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of ...

Denver Metro Life Sciences, Biotech & Quantum Conference 2026: Explore the research, investment, and real estate trends ...

VIS-101, purpose-designed to be best-in-class for retinal vascular diseases, is a tetravalent, dual VEGF-A X ANG-2 ...

T Biosciences, an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, today announced the appointment of Rebeca Villarreal-Barragan, MBA, as ...

T Biosciences, an immunotherapy company, has appointed Rebeca Villarreal-Barragan, MBA, as head of clinical operations.

Medicine is often seen as a world of science, compassion, and one-on-one patient care. Doctors are trained to diagnose ...

Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s prostate cancer candidate VIR-5500 through a collaboration that could generate more than $1.7 billion for the San ...

Astellas Pharma Inc. and Vir Biotechnology Inc. have entered into a global strategic collaboration to advance VIR-5500.

Whisper it, but we may finally be seeing the IPO window reopening in 2026. Biotech listings saw their heyday in the middle of the COVID-19 pandemic, when an incredible 87 U.S.-based drug developers ...